Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 1;115(10):980-997.
doi: 10.1002/bdr2.2176. Epub 2023 Apr 26.

A multi-program analysis of cleft lip with cleft palate prevalence and mortality using data from 22 International Clearinghouse for Birth Defects Surveillance and Research programs, 1974-2014

Affiliations

A multi-program analysis of cleft lip with cleft palate prevalence and mortality using data from 22 International Clearinghouse for Birth Defects Surveillance and Research programs, 1974-2014

Niall Mc Goldrick et al. Birth Defects Res. .

Abstract

Background: Cleft lip with cleft palate (CLP) is a congenital condition that affects both the oral cavity and the lips. This study estimated the prevalence and mortality of CLP using surveillance data collected from birth defect registries around the world.

Methods: Data from 22 population- and hospital-based surveillance programs affiliated with the International Clearinghouse for Birth Defects Surveillance and Research (ICBDSR) in 18 countries on live births (LB), stillbirths (SB), and elective terminations of pregnancy for fetal anomaly (ETOPFA) for CLP from 1974 to 2014 were analyzed. Prevalence and survival (survival for LB only) estimates were calculated for total and subclassifications of CLP and by pregnancy outcome.

Results: The pooled prevalence of total CLP cases was 6.4 CLP per 10,000 births. The prevalence of CLP and all of the pregnancy outcomes varied across programs. Higher ETOPFA rates were recorded in most European programs compared to programs in other continents. In programs reporting low ETOPFA rates or where there was no ascertainment of ETOPFA, the rate of CLP among LB and SB was higher compared to those where ETOPFA rates were ascertained. Overall survival for total CLP was 91%. For isolated CLP, the survival was 97.7%. CLP associated with multiple congenital anomalies had an overall survival of 77.1%, and for CLP associated with genetic/chromosomal syndromes, overall survival was 40.9%.

Conclusions: Total CLP prevalence reported in this study is lower than estimates from prior studies, with variation by pregnancy outcomes between programs. Survival was lower when CLP was associated with other congenital anomalies or syndromes compared to isolated CLP.

Keywords: congenital anomalies; craniofacial abnormalities; mortality; prevalence; surveillance.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Pooled prevalence per 10,000 births of total cleft lip with the cleft palate for each participating ICBDSR program for the period 1974–2014.
FIGURE 2
FIGURE 2
Prevalence by year of undifferentiated cleft lip with the cleft palate.
FIGURE 3
FIGURE 3
Quality indicators used by authors to assess data quality of data sets and inform inclusion criteria.

References

    1. Berkowitz S (2013). Cleft lip and palate: Diagnosis and management. (3 Aufl. ed.) Berlin: Springer-Verlag.
    1. Calzolari E, Rubies M, Neville AJ, & Bianchi F (2002). EUROCAT and orofacial clefts: The epidemiology of orofacial clefts in 30 european regions. Retrieved from Belfast: https://eu-rd-platform.jrc.ec.europa.eu/sites/default/files/eurocat-pub-... [Accessed on December 9, 2022].
    1. Christensen K, Juel K, Herskind AM, & Murray JC (2004). Long term follow up study of survival associated with cleft lip and palate at birth. BMJ, 328(7453), 1405. 10.1136/bmj.38106.559120.7C - DOI - PMC - PubMed
    1. Cobourne MT, & Sharpe PT (2012). Cleft lip and palate: Epidemiology, aetiology and treatment (Vol. 16). Basel: S. Karger AG.
    1. European Commission. (2022). EUROCAT data prevalence charts and tables. Retrieved from https://eu-rd-platform.jrc.ec.europa.eu/eurocat/eurocat-data/prevalence_en [Accessed on December 9, 2022].